Woodline Partners LP Acquires New Stake in Septerna, Inc. (NASDAQ:SEPN)

Woodline Partners LP bought a new position in shares of Septerna, Inc. (NASDAQ:SEPN) during the 4th quarter, HoldingsChannel reports. The institutional investor bought 300,000 shares of the company’s stock, valued at approximately $6,870,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of SEPN. Tower Research Capital LLC TRC purchased a new stake in Septerna during the fourth quarter worth about $25,000. New York State Common Retirement Fund purchased a new stake in Septerna during the 4th quarter worth approximately $32,000. Legal & General Group Plc purchased a new stake in Septerna during the 4th quarter worth approximately $42,000. Summit Investment Advisors Inc. acquired a new stake in Septerna during the 4th quarter worth approximately $45,000. Finally, BNP Paribas Financial Markets purchased a new position in Septerna in the 4th quarter valued at approximately $52,000.

Insiders Place Their Bets

In related news, CFO Gil M. Labrucherie purchased 6,282 shares of the company’s stock in a transaction on Tuesday, February 25th. The shares were bought at an average cost of $5.59 per share, for a total transaction of $35,116.38. Following the completion of the purchase, the chief financial officer now directly owns 36,282 shares of the company’s stock, valued at approximately $202,816.38. This trade represents a 20.94% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Alan Ezekowitz acquired 7,491 shares of the business’s stock in a transaction on Tuesday, March 4th. The shares were bought at an average cost of $6.35 per share, for a total transaction of $47,567.85. Following the acquisition, the director now owns 24,911 shares of the company’s stock, valued at $158,184.85. This represents a 43.00% increase in their position. The disclosure for this purchase can be found here. Insiders acquired 58,846 shares of company stock valued at $352,565 in the last ninety days. Insiders own 4.30% of the company’s stock.

Septerna Trading Down 3.1%

NASDAQ SEPN opened at $9.19 on Friday. Septerna, Inc. has a 52 week low of $4.17 and a 52 week high of $28.99. The firm has a 50 day moving average of $6.73 and a two-hundred day moving average of $13.82.

Septerna (NASDAQ:SEPN) last issued its earnings results on Thursday, May 15th. The company reported ($0.49) EPS for the quarter, missing analysts’ consensus estimates of ($0.38) by ($0.11). The company had revenue of $0.22 million for the quarter. As a group, analysts predict that Septerna, Inc. will post -7.11 EPS for the current year.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the company. Cantor Fitzgerald upped their price objective on Septerna from $20.00 to $25.00 and gave the stock an “overweight” rating in a research report on Friday, May 16th. Wells Fargo & Company upped their price target on Septerna from $11.00 to $18.00 and gave the stock an “equal weight” rating in a report on Friday, May 16th.

Septerna Company Profile

We are a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by our proprietary Native Complex Platform™. Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of our deep pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases.